Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.545
-0.022 (-3.81%)
At close: Dec 20, 2024, 4:00 PM
0.560
+0.015 (2.75%)
After-hours: Dec 20, 2024, 7:29 PM EST
MTNB Employees
Matinas BioPharma Holdings had 32 employees as of December 31, 2023. The number of employees decreased by 2 or -5.88% compared to the previous year.
Employees
32
Change (1Y)
-2
Growth (1Y)
-5.88%
Revenue / Employee
n/a
Profits / Employee
-$660,375
Market Cap
2.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Regional Health Properties | 114 |
| iSpecimen | 53 |
| Scinai Immunotherapeutics | 31 |
| LogicMark | 27 |
| ENDRA Life Sciences | 21 |
| Windtree Therapeutics | 20 |
| Catheter Precision | 14 |
| Entero Therapeutics | 9 |
MTNB News
- 7 weeks ago - Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - GlobeNewsWire
- 4 months ago - Matinas BioPharma Holdings, Inc. (MTNB) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 4 months ago - Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024 - GlobeNewsWire
- 6 months ago - Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program - GlobeNewsWire
- 6 months ago - Matinas BioPharma's Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. - GlobeNewsWire
- 7 months ago - New In Vitro Data Showing Matinas BioPharma's LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 - GlobeNewsWire
- 8 months ago - Matinas BioPharma Holdings, Inc. (MTNB) Q1 2024 Earnings Call Transcript - Seeking Alpha